+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

NRT Smoking Cessation Aids in Singapore

  • PDF Icon

    Report

  • 21 Pages
  • October 2025
  • Region: Singapore
  • Euromonitor International
  • ID: 4432192
Value sales of NRT smoking cessation aids are increasing in Singapore 2025, helped by persistent government action to reduce smoking and vaping prevalence. The Singapore government is maintaining a strong focus on tobacco-control measures, guided by the ACE Clinical Guideline (ACG), which highlights the importance of sustained support for smokers seeking to quit.

This NRT Smoking Cessation Aids in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2025, allowing you to identify the sectors driving growth. Forecasts to 2030 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2025 DEVELOPMENTS
  • Government steps up effort to curb vaping and smoking culture among younger generations
  • Johnson & Johnson leads with Nicorette benefiting from broad distribution
  • Pharmacies gains greater share in 2025, rising fastest among distribution channels
PROSPECTS AND OPPORTUNITIES
  • Rising health consciousness set to see consumers quit smoking through combination of NRT smoking cessation aids and counselling
  • Brand will play increasingly important role in raising awareness
  • Government to ensure low smoking prevalence through implementation of comprehensive tobacco-control strategy
CATEGORY INDICATORS
  • Table 1 Number of Smokers by Gender 2020-2025
CATEGORY DATA
  • Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
  • Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2021-2025
  • Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2022-2025
  • Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2025-2030
  • Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
  • Consumer Health in 2025: The big picture
  • Key trends in 2025
  • Competitive landscape
  • Channel developments
  • What next for Consumer Health?
MARKET INDICATORS
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
  • Table 9 Life Expectancy at Birth 2020-2025
MARKET DATA
  • Table 10 Sales of Consumer Health by Category: Value 2020-2025
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2020-2025
  • Table 12 NBO Company Shares of Consumer Health: % Value 2021-2025
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2022-2025
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
  • Table 15 Distribution of Consumer Health by Format: % Value 2020-2025
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2025
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2025-2030
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2024-2025
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 2 Research Sources